Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


A marketing authorization application has been submitted to the European Medicines Agency for neratinib as a potential extended adjuvant therapy for patients with HER2-positive early stage breast cancer following 12 months of trastuzumab.

EMA Approval Sought for Neratinib in HER2+ Breast Cancer

Hyman B. Muss, MD, School of Medicine, University of North Carolina (UNC)-Chapel Hill, Breast Cancer, Geriatric Oncology Program, Mary Jones Hudson Distinguished Professorship in Geriatric Oncology, discusses assessing treatment response in patients with metastatic breast cancer.

Dr. Muss on Assessing Treatment Response in Patients With Metastatic Breast Cancer

Final Thoughts on Advanced Breast Cancer

Practice-Changing Results from the MINDACT Trial

AC versus TaxAC in High-Risk HER2-Negative MBC

Adjuvant Therapy for Breast Cancer

Immunotherapy for TNBC

Is There a Role for TNBC Subtyping?

Biosimilar Trastuzumab in HER2-Positive Breast Cancer

Neratinib and HER2 Activating Mutations in Breast Cancer 

Patient Selection for Neratinib in Metastatic Breast Cancer

The Emerging Role of Neratinib in HER2+ MBC

PHEREXA Trial in HER2+ Disease

Adjuvant TDM-1 and the KRISTINE Trial 

What is New for HER2 MBC?

The Emerging Role of PI3K Inhibition in Breast Cancer

The Ongoing Role of Everolimus in ER-Positive MBC

FDA Breakthrough Status for Abemaciclib

CDK4/6 Inhibitors in Hormone Receptor-Driven MBC

ESR Mutations and Resistance to Endocrine Therapy in Breast Cancer

HER2+ Breast Cancer

The OncLive Neoadjuvant HER2+ Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with HER2-positive breast cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research in HER2-positive breast cancer.

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Breast Cancer

ELI-22-OSD1261 - /clinical/colorectal-cancer

Breast Cancer | Specialty